Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
4.620
-0.160 (-3.35%)
At close: Dec 5, 2025, 4:00 PM EST
4.630
+0.010 (0.21%)
After-hours: Dec 5, 2025, 7:57 PM EST
Achieve Life Sciences Employees
Achieve Life Sciences had 25 employees as of December 31, 2024. The number of employees increased by 3 or 13.64% compared to the previous year.
Employees
25
Change (1Y)
3
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$2,093,840
Market Cap
245.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ACHV News
- 4 weeks ago - Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - GlobeNewsWire
- 4 weeks ago - Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation - GlobeNewsWire
- 5 weeks ago - Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025 - GlobeNewsWire
- 6 weeks ago - Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer - GlobeNewsWire
- 6 weeks ago - Achieve: Expedited Review Of Cytisinicline Sets The Stage For Development Expansion - Seeking Alpha
- 7 weeks ago - Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation - GlobeNewsWire
- 2 months ago - Achieve Life Sciences Announces Granting of New Hire Inducement Awards - GlobeNewsWire